![Stefan Seuferling (links), der neue Vorstandsvorsitzende der Raumedic AG, und Martin Bayer, CEO und Präsident der US-Gesellschaft, wollen sich stärker auf die Bedürfnisse ihrer Zielmärkte konzentrieren. / Stefan Seuferling (left), the new Chairman of the Executive Board of Raumedic AG, and Martin Bayer, CEO and President of the U.S. business operation, plan to focus more closely on the needs of their target markets. Stefan Seuferling (links), der neue Vorstandsvorsitzende der Raumedic AG, und Martin Bayer, CEO und Präsident der US-Gesellschaft, wollen sich stärker auf die Bedürfnisse ihrer Zielmärkte konzentrieren. / Stefan Seuferling (left), the new Chairman of the Executive Board of Raumedic AG, and Martin Bayer, CEO and President of the U.S. business operation, plan to focus more closely on the needs of their target markets.](/uploads/images/_scale/raumedic_seuferling_bayer_web_626x343.jpg)
New Raumedic leadership duo to intensify market focus
The medical technology manufacturer Raumedic has re-assigned responsibilities among its top management team. Executive Board member Stefan Seuferling has been named Chairman of the Executive Board of Raumedic AG by the company’s Board of Directors in a decision that took effect March 15. Martin Ba…